2 withdrawn, 1 completed, 1 terminated, 1 unknown. 3 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Not applicable | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Integrase Inhibitors: new trials by email Literature Review of Integrase Inhibitors trials Research Report on Integrase Inhibitors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Change in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTI Integrase inhibitor, Doravirine + tenofovir DF + lamivudine - HIV, HIV Associate Weight Loss | Phase 4 | Unknown | Instituto Mexicano del Seguro Social | 108 | 2024-08-14 | 2024-09-19 |
| Protease Inhibitor Vs. Raltegravir-based ART and Inflammation in HIV Infection Integrase Inhibitor - HIV | Phase 4 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 6 | 2017-01-20 | 2024-11-20 |
| Raltegravir Activity In Lymphoid Tissues Efavirenz + Tenofovir DF/Emtricitabine, Raltegravir + Tenofovir DF/Emtricitabine, Colonoscopy with biopsies - HIV Infection, HIV Infections | Not applicable | Withdrawn | University of Minnesota | 2009-03-01 | 2015-05-18 | |
| A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients enfuvirtide [Fuzeon], Optimized background ARV, Integrase inhibitor - HIV Infections | Phase 4 | Terminated | Hoffmann-La Roche | 29 | 2007-06-01 | 2011-07-22 |
| A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects HIV Integrase Inhibitor (BMS-707035) - HIV Infections | Phase 2 | Withdrawn | Bristol-Myers Squibb | 2007-02-01 | 2012-04-27 |
HIV Infections (3) · Body Weight Changes (1) · Infections (1) · Weight Loss (1)
Bristol-Myers Squibb (1) · Hoffmann-La Roche (1) · Instituto Mexicano del Seguro Social (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · University of Minnesota (1)
United States (2) · Canada (1) · Mexico (1) · Puerto Rico (1)
Jean-Pierre Routy, MD; FRCPC (1) · Timothy W Schacker, M.D. (1)